Yubo International Biotech YBGJ Income Statement (2009-2026)

OTC YBGJ
$0.01 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST
Reported Financials

Yubo International Biotech Quarterly Income Statement

Periods 71 quarters
Latest Sep 2026

Yubo International Biotech reported net income of -$0.20M for the quarter ended Sep 2026. This income statement covers 71 quarters of results from Feb 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Feb2009 May2009 Aug2009 Nov2009 Feb2010 May2010 Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Mar2020 May2020 Aug2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Revenue & cost
Revenue
0.33M0.02M0.01M0.01M0.07M0.16M0.00M0.43M0.02M0.00M-18.000.01M
Cost of RevenueCost of Rev
0.11M0.01M0.00M0.00M0.04M0.10M545.000.08M0.00M827.00-5.000.00M
Gross Profit
0.22M0.01M0.01M0.01M0.03M0.06M885.000.34M0.02M0.00M-13.000.01M
Operating items
Amortization - Intangibles
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M162.000.00M
Depreciation & Amortization - TotalDep. & Amort. (Tot)
-0.01M
Selling, General & AdministrativeSG&A
Other Operating ExpensesOther Opex
0.85M0.06M0.04M0.02M0.12M0.09M0.15M0.01M0.06M0.09M0.14M0.09M0.03M0.04M-0.03M0.03M0.10M0.04M0.04M0.01M
Operating ExpensesOpex
0.61M0.59M0.50M0.25M-0.07M0.37M0.37M0.34M0.54M0.41M0.47M0.53M0.36M0.47M0.25M0.31M0.29M0.29M0.24M0.20M
Operating IncomeOp. Inc
-0.39M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.41M-0.47M-0.53M-0.36M-0.47M-0.25M-0.31M-0.29M-0.29M-0.24M-0.20M
Non-operating items
Non Operating Interest Expenses
13.0059.00174.00135.0051.00130.0084.0017.0049.0023.0018.00
Other Non Operating IncomeOther Non Op Inc.
-0.65M-0.05M50.000.01M0.04M0.04M-51.00-130.00-61.00-84.00-0.13M-0.09M0.00M-19.00-23.00-18.00-183.00-0.01M-0.08M-338.00
Non Operating IncomeNon Op. Inc.
-19.00-18.00-0.01M-338.00
Net income details
EBIT
-0.39M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.41M-0.47M-0.53M-0.36M-0.47M-0.25M-0.31M-0.29M-0.29M-0.24M-0.20M
EBT
-0.40M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.41M-0.60M-0.62M-0.35M-0.47M-0.25M-0.31M-0.29M-0.30M-0.27M-0.20M
Income After Tax
-0.40M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.41M-0.60M-0.62M-0.35M-0.47M-0.25M-0.31M-0.29M-0.30M-0.27M-0.20M
Income from Continuing OperationsIncome (Continuing)
-0.40M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.41M-0.60M-0.62M-0.35M-0.47M-0.25M-0.31M-0.29M-0.30M-0.27M-0.20M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
-0.28M-0.58M-0.49M-0.24M0.06M-0.32M-0.37M0.01M-0.60M-0.41M-0.60M-0.65M-0.49M-0.47M-0.25M-0.31M-0.29M-0.30M-0.35M-0.20M
Net Income Attributable to Noncontrolling InterestsNCI Net Income
-0.03M-0.07M-0.04M-0.06M0.03M-0.02M-0.03M-0.02M-0.02M-0.02M-0.02M
Income towards Parent CompanyParent Net Inc
-0.40M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.38M-0.53M-0.62M-0.15M-0.44M-0.23M-0.28M-0.26M-0.27M-0.27M-0.19M
Net Income towards Common StockholdersNet Income
-0.40M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-0.52M-0.38M-0.53M-0.58M-0.29M-0.44M-0.23M-0.28M-0.26M-0.27M-0.27M-0.19M
Additional items
EPS (Basic)
0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS (Diluted)
0.000.000.000.000.000.000.000.00-0.04-0.030.000.000.000.000.000.000.000.000.000.00
Shares Outstanding
118.13M118.18M118.18M118.70M118.72M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M119.82M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
118.13M118.18M118.18M118.70M118.72M119.82M119.82M119.82M11.98M11.98M119.82M119.82M119.82M119.82M119.82M147.87M139.64M170.42M170.42M170.42M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
118.13M118.18M118.18M118.70M118.72M119.82M119.82M119.82M119.82M119.82M119.82M
EBITDA
-0.38M-0.57M-0.49M-0.23M0.11M-0.31M-0.35M0.05M-0.40M-0.36M-0.42M-0.48M-0.31M-0.42M-0.20M-0.27M-0.24M-0.26M-0.24M-0.20M
Interest ExpensesInt Expense
13.0059.00174.00135.0051.00130.0084.0017.0049.0023.0018.00

Yubo International Biotech Income Statement API

Pull Yubo International Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=YBGJ&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY